Drugmakers plan to raise U.S. prices on at least 250 branded medications including Pfizer COVID-19 treatment Paxlovid, ...

Millions of Medicare enrollees are likely to see relief in 2025 when a $2,000 cap on out-of-pocket prescription drug-spending ...

A key cost-saving provision of the Inflation Reduction Act (IRA) goes into effect in the new year, limiting annual ...

The reality is that there's a long list of middlemen that obfuscate ... "It's very, very simple. If all drug manufacturers would sell to Cost Plus Drugs at a competitive price, then all drugs ...

Penn Medicine has enlisted Mark Cuban Cost Plus Drug Company to secure key generics for its retail pharmacy network. Penn will lean on the Cost Plus Marketplace for 100 of the most frequently ...

The nonprofit health system’s new partnership with the Mark Cuban Cost Plus Drug Co. marketplace for businesses officially goes into effect in January. The marketplace is part of Cuban’s larger ...

“I’m not trying to land on Mars,” Cost Plus Drugs founder ... its entire price list, something that’s always been incredibly hard to obtain from other drug providers for consumers and ...

The Penn Medicine partnership with Mark Cuban's Cost Plus Drug Co. is designed to cut the health system's drug costs and improve access to prescription medicines. Penn Medicine has entered into a ...

To reduce medication costs and mitigate drug shortages, Penn Medicine is uniting with Mark Cuban Cost Plus Drug Co., the health system said Dec. 6. The Philadelphia-based organization will buy the ...

thanks to a new alliance between PharmPix and Mark Cuban Cost Plus Drug Company (Cost Plus Drugs). With over 90% of prescribed drugs in the U.S. being generics, PharmPix and Cost Plus Drugs are ...